Carregant...
CAR-T细胞桥接异基因造血干细胞移植治疗复发/难治急性B淋巴细胞白血病的临床分析
OBJECTIVE: This study aims to investigate the efficacy and safety of chimeric antigen receptor（CAR）T-cell bridging allogeneic hematopoietic stem cell transplantation（allo-HSCT）in the treatment of recurrent and refractory acute B-lymphocytic leukemia（R/R B-ALL）. METHODS: A total of 50 R/R B-ALL patie...
Guardat en:
| Publicat a: | Zhonghua Xue Ye Xue Za Zhi |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Editorial office of Chinese Journal of Hematology
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7595870/ https://ncbi.nlm.nih.gov/pubmed/33113601 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3760/cma.j.issn.0253-2727.2020.09.002 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|